SHAREHOLDERS AGREEMENTShareholders Agreement • February 1st, 2010 • OEP CHME Holdings, LLC • Wholesale-drugs, proprietaries & druggists' sundries • New York
This SHAREHOLDERS AGREEMENT (this “Agreement”) is made and entered into as of December 31, 2009 by and among, (a) Mr. Yang Senshan (“Mr. Yang”), (b) Ms. Liu Minhua (“Ms. Liu”), (c) Mr. Liu Junhua, (“Mr. Liu,” together with Mr. Yang and Ms. Liu, the “Executive Shareholders”) and (d) OEP CHME Holdings, LLC, a Delaware limited liability company (“OEP”).
STOCK SUBSCRIPTION AGREEMENTStock Subscription Agreement • February 1st, 2010 • OEP CHME Holdings, LLC • Wholesale-drugs, proprietaries & druggists' sundries • New York
This STOCK SUBSCRIPTION AGREEMENT (this “Agreement”) is made and entered into as of December 31, 2009 by and among (a) China Medicine Corporation, a Nevada corporation (the “Company”), (b) Mr. Yang Senshan, (the “Executive Shareholder”), and (c) OEP CHME Holdings, LLC, a Delaware limited liability company (“Investor”).
SHARE PLEDGE AGREEMENTShare Pledge Agreement • February 1st, 2010 • OEP CHME Holdings, LLC • Wholesale-drugs, proprietaries & druggists' sundries • New York
THIS PLEDGE AGREEMENT (this “Agreement”), is made as of January 29, 2010, by Mr. Yang Senshan, an individual (the “Pledgor”), in favor of OEP CHME Holdings, LLC, a Delaware limited liability company (the “Pledgee”).
ContractEscrow Agreement • September 18th, 2012 • OEP CHME Holdings, LLC • Wholesale-drugs, proprietaries & druggists' sundries • Hong Kong
ContractEscrow Funds Loan Agreement • September 18th, 2012 • OEP CHME Holdings, LLC • Wholesale-drugs, proprietaries & druggists' sundries • New York
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • February 1st, 2010 • OEP CHME Holdings, LLC • Wholesale-drugs, proprietaries & druggists' sundries
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned Reporting Persons hereby agrees to the joint filing, on behalf of each of them, of a statement on Schedule 13D (including amendments thereto) with respect to shares of Common Stock, $0.001 par value per share, of China Medicine Corporation, and that this Agreement be included as an Exhibit to such joint filing. The undersigned acknowledge and agree that all subsequent amendments to Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained in Schedule 13D and any amendments thereto, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or h
ContractEscrow Agreement • September 18th, 2012 • OEP CHME Holdings, LLC • Wholesale-drugs, proprietaries & druggists' sundries
ESCROW AGREEMENTEscrow Agreement • February 1st, 2010 • OEP CHME Holdings, LLC • Wholesale-drugs, proprietaries & druggists' sundries • New York
This ESCROW AGREEMENT (this “Agreement”) is made and entered into as of January 29, 2010, by and among OEP CHME Holdings, LLC, a Delaware limited liability company (“OEP”), China Medicine Corporation, a Nevada corporation (the “Company”) and JPMorgan Chase Bank, N.A., as Escrow Agent (the “Escrow Agent”).
